社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Chillman
IP属地：未知
+关注
帖子 · 270
帖子 · 270
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Chillman
Chillman
·
2021-12-09
Ok
非常抱歉，此主贴已删除
看
2,329
回复
评论
点赞
3
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-12-05
Ok
非常抱歉，此主贴已删除
看
2,775
回复
评论
点赞
3
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-12-05
Ok
非常抱歉，此主贴已删除
看
3,043
回复
评论
点赞
2
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-12-01
Ok
非常抱歉，此主贴已删除
看
3,120
回复
2
点赞
6
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-11-30
Nice
Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.<blockquote>道琼斯期货跌超1%，标普500期货跌0.9%，纳斯达克100期货跌0.6%。</blockquote>
Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.The hea
Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.<blockquote>道琼斯期货跌超1%，标普500期货跌0.9%，纳斯达克100期货跌0.6%。</blockquote>
看
2,702
回复
评论
点赞
5
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-11-29
Wow
Merck stock dipped more than 4% in morning trading<blockquote>默克股价早盘下跌逾4%</blockquote>
Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi
Merck stock dipped more than 4% in morning trading<blockquote>默克股价早盘下跌逾4%</blockquote>
看
2,123
回复
1
点赞
8
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-11-28
Nice
非常抱歉，此主贴已删除
看
3,371
回复
评论
点赞
2
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-11-28
❌❌❌❌❌ boooooo
非常抱歉，此主贴已删除
看
3,859
回复
3
点赞
5
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-11-26
Ok
Ocugen Shares Fall After Its Pivotal COVID-19 Vaccine Trial Put On FDA Hold<blockquote>Ocugen关键的COVID-19疫苗试验被FDA搁置后股价下跌</blockquote>
The FDA has issued a clinical hold on Ocugen Inc's Investigational New Drug application (IND) to eva
Ocugen Shares Fall After Its Pivotal COVID-19 Vaccine Trial Put On FDA Hold<blockquote>Ocugen关键的COVID-19疫苗试验被FDA搁置后股价下跌</blockquote>
看
2,032
回复
1
点赞
1
编组 21备份 2
分享
举报
Chillman
Chillman
·
2021-11-24
Like
非常抱歉，此主贴已删除
看
1,843
回复
评论
点赞
5
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3558275010133966","uuid":"3558275010133966","gmtCreate":1611245073666,"gmtModify":1622023653315,"name":"Chillman","pinyin":"chillman","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":21,"headSize":580,"tweetSize":270,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.01","exceedPercentage":"60.75%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.09","exceedPercentage":"80.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":602250072,"gmtCreate":1639031184031,"gmtModify":1639031224801,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602250072","repostId":"2190169579","repostType":4,"isVote":1,"tweetType":1,"viewCount":2329,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608836540,"gmtCreate":1638676820635,"gmtModify":1638676820828,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608836540","repostId":"2188853578","repostType":4,"isVote":1,"tweetType":1,"viewCount":2775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608836293,"gmtCreate":1638676807504,"gmtModify":1638676807504,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608836293","repostId":"2188853578","repostType":4,"isVote":1,"tweetType":1,"viewCount":3043,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609704578,"gmtCreate":1638322826048,"gmtModify":1638322826197,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609704578","repostId":"2188532575","repostType":4,"isVote":1,"tweetType":1,"viewCount":3120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609161314,"gmtCreate":1638252985158,"gmtModify":1638252985340,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609161314","repostId":"1137140236","repostType":4,"repost":{"id":"1137140236","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638251196,"share":"https://www.laohu8.com/m/news/1137140236?lang=zh_CN&edition=full","pubTime":"2021-11-30 13:46","market":"us","language":"en","title":"Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.<blockquote>道琼斯期货跌超1%，标普500期货跌0.9%，纳斯达克100期货跌0.6%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1137140236","media":"Tiger Newspress","summary":"Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.The hea","content":"<p>Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.<img src=\"https://static.tigerbbs.com/1b3fd4d2c9b92c7ea11f6af363320cd7\" tg-width=\"377\" tg-height=\"185\" referrerpolicy=\"no-referrer\">The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p><p><blockquote>道琼斯期货跌逾1%，标准普尔500指数期货跌0.9%，纳斯达克100指数期货跌0.6%。制药商Moderna的负责人表示，COVID-19疫苗不太可能像以前那样有效对抗冠状病毒的奥密克戎变种，这引发了金融市场对大流行轨迹的新担忧。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.<blockquote>道琼斯期货跌超1%，标普500期货跌0.9%，纳斯达克100期货跌0.6%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.<blockquote>道琼斯期货跌超1%，标普500期货跌0.9%，纳斯达克100期货跌0.6%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-30 13:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.<img src=\"https://static.tigerbbs.com/1b3fd4d2c9b92c7ea11f6af363320cd7\" tg-width=\"377\" tg-height=\"185\" referrerpolicy=\"no-referrer\">The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.</p><p><blockquote>道琼斯期货跌逾1%，标准普尔500指数期货跌0.9%，纳斯达克100指数期货跌0.6%。制药商Moderna的负责人表示，COVID-19疫苗不太可能像以前那样有效对抗冠状病毒的奥密克戎变种，这引发了金融市场对大流行轨迹的新担忧。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137140236","content_text":"Dow Jones futures fell more than 1%, S&P 500 futures fell 0.9%, Nasdaq 100 futures fell 0.6%.The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic.","news_type":1,"symbols_score_info":{"ESmain":0.9,"YMmain":0.9,"NQmain":0.9}},"isVote":1,"tweetType":1,"viewCount":2702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600712164,"gmtCreate":1638197517725,"gmtModify":1638197518092,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600712164","repostId":"1137393357","repostType":4,"repost":{"id":"1137393357","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638197348,"share":"https://www.laohu8.com/m/news/1137393357?lang=zh_CN&edition=full","pubTime":"2021-11-29 22:49","market":"us","language":"en","title":"Merck stock dipped more than 4% in morning trading<blockquote>默克股价早盘下跌逾4%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1137393357","media":"Tiger Newspress","summary":"Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi ","content":"<p>Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi Research.</p><p><blockquote>花旗研究部将默克股票评级从买入下调至中性，早盘交易中下跌超过4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/921cc70c00deb0f565b98bc2a7218479\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Disappointing results for some major drugs has limited the upside for Merck’s stock, according to Citi.</p><p><blockquote>花旗表示，一些主要药物令人失望的业绩限制了默克股票的上涨空间。</blockquote></p><p> Analyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.</p><p><blockquote>分析师安德鲁·鲍姆(Andrew Baum)将默克公司的评级从买入下调至中性，他在周一给客户的一份报告中表示，该公司艾滋病毒药物islatravir的开发困难正在削弱默克公司的长期潜力。</blockquote></p><p> “Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.</p><p><blockquote>“我们对MRK的长期投资论点是基于对MRK产品线的低估，尤其是用于艾滋病毒的islatravir，以帮助抵消即将推出的Keytruda[排他性丧失]……我们已从模型中删除了40亿美元的风险调整后2030年估计，减少了我们的每股收益预期高达10%，”该报告称。</blockquote></p><p> Citi cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.</p><p><blockquote>花旗将默克的目标价从每股105美元下调至85美元。新目标比该股周五收盘价高出约7%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck stock dipped more than 4% in morning trading<blockquote>默克股价早盘下跌逾4%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck stock dipped more than 4% in morning trading<blockquote>默克股价早盘下跌逾4%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-29 22:49</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi Research.</p><p><blockquote>花旗研究部将默克股票评级从买入下调至中性，早盘交易中下跌超过4%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/921cc70c00deb0f565b98bc2a7218479\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Disappointing results for some major drugs has limited the upside for Merck’s stock, according to Citi.</p><p><blockquote>花旗表示，一些主要药物令人失望的业绩限制了默克股票的上涨空间。</blockquote></p><p> Analyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.</p><p><blockquote>分析师安德鲁·鲍姆(Andrew Baum)将默克公司的评级从买入下调至中性，他在周一给客户的一份报告中表示，该公司艾滋病毒药物islatravir的开发困难正在削弱默克公司的长期潜力。</blockquote></p><p> “Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.</p><p><blockquote>“我们对MRK的长期投资论点是基于对MRK产品线的低估，尤其是用于艾滋病毒的islatravir，以帮助抵消即将推出的Keytruda[排他性丧失]……我们已从模型中删除了40亿美元的风险调整后2030年估计，减少了我们的每股收益预期高达10%，”该报告称。</blockquote></p><p> Citi cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.</p><p><blockquote>花旗将默克的目标价从每股105美元下调至85美元。新目标比该股周五收盘价高出约7%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137393357","content_text":"Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi Research.\n\nDisappointing results for some major drugs has limited the upside for Merck’s stock, according to Citi.\nAnalyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.\n“Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.\nCiti cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.","news_type":1,"symbols_score_info":{"MRK":0.9}},"isVote":1,"tweetType":1,"viewCount":2123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600155331,"gmtCreate":1638102880246,"gmtModify":1638102880394,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600155331","repostId":"2186328507","repostType":4,"isVote":1,"tweetType":1,"viewCount":3371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600932523,"gmtCreate":1638033733104,"gmtModify":1638033733253,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"❌❌❌❌❌ boooooo","listText":"❌❌❌❌❌ boooooo","text":"❌❌❌❌❌ boooooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/600932523","repostId":"2186344334","repostType":4,"isVote":1,"tweetType":1,"viewCount":3859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877283354,"gmtCreate":1637935775242,"gmtModify":1637935775393,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877283354","repostId":"1136453460","repostType":4,"repost":{"id":"1136453460","kind":"news","pubTimestamp":1637933775,"share":"https://www.laohu8.com/m/news/1136453460?lang=zh_CN&edition=full","pubTime":"2021-11-26 21:36","market":"us","language":"en","title":"Ocugen Shares Fall After Its Pivotal COVID-19 Vaccine Trial Put On FDA Hold<blockquote>Ocugen关键的COVID-19疫苗试验被FDA搁置后股价下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1136453460","media":"Benzinga","summary":"The FDA has issued a clinical hold on Ocugen Inc's Investigational New Drug application (IND) to eva","content":"<p><div> The FDA has issued a clinical hold on Ocugen Inc's Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152 (known as Covaxin outside the U.S.). The FDA plans to ...</p><p><blockquote><div>FDA已对Ocugen Inc的研究性新药申请(IND)发布临床搁置，以评估COVID-19候选疫苗BBV152（在美国以外称为科瓦克辛）。食品和药物管理局计划...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/11/24302992/ocugen-shares-fall-after-its-pivotal-covid-19-vaccine-trial-put-on-fda-hold\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/11/24302992/ocugen-shares-fall-after-its-pivotal-covid-19-vaccine-trial-put-on-fda-hold\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen Shares Fall After Its Pivotal COVID-19 Vaccine Trial Put On FDA Hold<blockquote>Ocugen关键的COVID-19疫苗试验被FDA搁置后股价下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen Shares Fall After Its Pivotal COVID-19 Vaccine Trial Put On FDA Hold<blockquote>Ocugen关键的COVID-19疫苗试验被FDA搁置后股价下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-26 21:36</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> The FDA has issued a clinical hold on Ocugen Inc's Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152 (known as Covaxin outside the U.S.). The FDA plans to ...</p><p><blockquote><div>FDA已对Ocugen Inc的研究性新药申请(IND)发布临床搁置，以评估COVID-19候选疫苗BBV152（在美国以外称为科瓦克辛）。食品和药物管理局计划...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/11/24302992/ocugen-shares-fall-after-its-pivotal-covid-19-vaccine-trial-put-on-fda-hold\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/11/24302992/ocugen-shares-fall-after-its-pivotal-covid-19-vaccine-trial-put-on-fda-hold\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/general/biotech/21/11/24302992/ocugen-shares-fall-after-its-pivotal-covid-19-vaccine-trial-put-on-fda-hold\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://www.benzinga.com/general/biotech/21/11/24302992/ocugen-shares-fall-after-its-pivotal-covid-19-vaccine-trial-put-on-fda-hold","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136453460","content_text":"The FDA has issued a clinical hold on Ocugen Inc's Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152 (known as Covaxin outside the U.S.).\n\nThe FDA plans to identify the specific deficiencies that are the basis for clinical hold and information on addressing those deficiencies.\nThe Company expects to receive formal written communication with the additional information from the FDA and plans to work with the agency to resolve its questions as promptly as possible.\nBBV152 is an investigational vaccine candidate product in the U.S. It was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology.\nCovaxin is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform.\nPrice Action: OCGN shares are down 16% at $5.94 during the premarket session on the last check Friday.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2032,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874622069,"gmtCreate":1637768346109,"gmtModify":1637768346228,"author":{"id":"3558275010133966","authorId":"3558275010133966","name":"Chillman","avatar":"https://static.tigerbbs.com/26d692768260a0369516e9c9a49897ec","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3558275010133966","authorIdStr":"3558275010133966"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874622069","repostId":"1119170686","repostType":4,"isVote":1,"tweetType":1,"viewCount":1843,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}